Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record displays details for a completed non-small cell lung cancer study evaluating viagenpumatucel-L in combination with other therapies. It includes participant eligibility, treatment plans, outcome measures, study dates, and related documents.
    Difference
    65%
    Check dated 2026-11-07T16:49:33.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T17:02:22.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-24T22:33:48.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T22:40:31.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-10T22:29:02.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    No changes were provided in the dataset. There are no additions or deletions to interpret in the page context.
    Difference
    0.2%
    Check dated 2026-09-26T22:08:31.000Z thumbnail image

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.